Sponsor:
Beijing Luzhu Biotechnology Co., Ltd.
Code:
NCT05750017
Conditions
Herpes Zoster
Vaccine-Preventable Diseases
Eligibility Criteria
Sex: All
Age: 50 - 70
Healthy Volunteers: Accepted
Interventions
Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
High Dose Recombinant Herpes Zoster Vaccine (LZ901)
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-19. This information was provided to ClinicalTrials.gov by Beijing Luzhu Biotechnology Co., Ltd. on 2023-03-27.